Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth
Open accessAbstract
Aptamers, oligonucleotides able to avidly bind cellular targets, are emerging as promising therapeutic agents, analogous to monoclonal antibodies. We selected from a DNA library an aptamer specifically recognizing human epidermal growth factor receptor 2 (ErbB-2/HER2), a receptor tyrosine kinase, which is overexpressed in a variety of human cancers, including breast and gastric tumors. Treatment of human gastric cancer cells with a trimeric version (42 nucleotides) of the selected aptamer (14 nucleotides) resulted in reduced cell growth in vitro, but a monomeric version was ineffective. Likewise, when treated with the trimeric aptamer, animals bearing tumor xenografts of human gastric origin reflected reduced rates of tumor growth. The antitumor effect of the aptamer was nearly twofold stronger than that of a monoclonal anti–ErbB-2/HER2 antibody. Consistent with aptamer-induced intracellular degradation of ErbB-2/HER2, incubation of gastric cancer cells with the trimeric aptamer promoted translocation of ErbB-2/HER2 from the cell surface to cytoplasmic puncta. This translocation was associated with a lysosomal hydrolase-dependent clearance of the ErbB-2/HER2 protein from cell extracts. We conclude that targeting ErbB-2/HER2 with DNA aptamers might retard the tumorigenic growth of gastric cancer by means of accelerating lysosomal degradation of the oncoprotein. This work exemplifies the potential pharmacological utility of aptamers directed at cell surface proteins, and it highlights an endocytosis-mediated mechanism of tumor inhibition.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SELEX allows natural selection on oligonucleotides by iterative amplification and selection.
“In fact, it has become possible to perform natural selection on oligonucleotides by iterative amplification and selection processes using a technique called systematic evolution of ligands by exponential enrichment, or SELEX.”
From Towards open-ended evolution in self-replicating molecular systems (2017) · cites this paper as [43]
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,421 · see citing works
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,845 · see citing works
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974 · see citing works
Self-citationInhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768 · see citing works
EGFR Antagonists in Cancer Treatment
Ciardiello, F., & Tortora, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707704 · Cited by 2,063 · see citing works
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,667 · see citing works
SELEX—A (r)evolutionary method to generate high-affinity nucleic acid ligands
Stoltenburg, R., Reinemann, C., & Strehlitz, B. (2007) · Biomolecular Engineering · doi:10.1016/j.bioeng.2007.06.001 · Cited by 1,432 · see citing works
Analytical applications of aptamers
Tombelli, S., Minunni, M., & Mascini, M. (2004) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2004.11.006 · Cited by 1,020 · see citing works
Dassie, J. P., Liu, X., Thomas, G. S., Whitaker, R. M., Thiel, K. W., Stockdale, K. R., Meyerholz, D. K., McCaffrey, A. P., McNamara, J. O., & Giangrande, P. H. (2009) · Nature Biotechnology · doi:10.1038/nbt.1560 · Cited by 591 · see citing works
Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding
Bates, P. J., Kahlon, J. B., Thomas, S. D., Trent, J. O., & Miller, D. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26369 · Cited by 407 · see citing works
Klapper, L. N., Waterman, H., Sela, M., & Yarden, Y. (2000) · PubMed · Cited by 351 · see citing works
Self-citationAptamer Modules as Sensors and Detectors
Famulok, M., & Mayer, G. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000293 · Cited by 301 · see citing works
Friedman, L. M., Rinon, A., Schechter, B., Lyass, L., Lavi, S., Bacus, S. S., Sela, M., & Yarden, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409610102 · Cited by 252 · see citing works
Self-citationInhibition of Cell Proliferation by an Anti-EGFR Aptamer
Li, N., Nguyen, H. H., Byrom, M., & Ellington, A. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020299 · Cited by 206 · see citing works
Chen, C. B., Chernis, G. A., Hoang, V. Q., & Landgraf, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1332660100 · Cited by 190 · see citing works
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death
Esposito, C. L., Passaro, D., Longobardo, I., Condorelli, G., Marotta, P., Affuso, A., de Franciscis, V., & Cerchia, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024071 · Cited by 182 · see citing works
Ben-Kasus, T., Schechter, B., Lavi, S., Yarden, Y., & Sela, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812059106 · Cited by 173 · see citing works
Self-citationCELL-SELEX: Novel Perspectives of Aptamer-Based Therapeutics
Guo, K., Ziemer, G., Paul, A., & Wendel, H. P. (2008) · International Journal of Molecular Sciences · doi:10.3390/ijms9040668 · Cited by 169 · see citing works
Kasprzyk, P. G., Song, S. U., Fiore, P. P. D., & King, C. R. (1992) · PubMed · Cited by 151 · see citing works
Spangler, J. B., Neil, J. R., Abramovitch, S., Yarden, Y., White, F. M., Lauffenburger, D. A., & Wittrup, K. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913476107 · Cited by 147 · see citing works
Self-citationIn Vitro Selection of RNA Aptamer and Specific Targeting of ErbB2 in Breast Cancer Cells
Kim, M. Y., & Jeong, S. (2011) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0283 · Cited by 89 · see citing works
Systems Biology of Growth Factor‐Induced Receptor Endocytosis
Zwang, Y., & Yarden, Y. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00870.x · Cited by 87 · see citing works
Self-citationDastjerdi, K., Tabar, G. H., Dehghani, H., & Haghparast, A. (2011) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.36 · Cited by 42 · see citing works
10 20 Fold aptamer library amplification without gel purification
Crameri, A., & Stemmer, W. P. C. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.18.4410 · Cited by 35 · see citing works
Flanagan, J. G., & Leder, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.21.8057 · Cited by 15 · see citing works
Targeting of Antibodies Using Aptamers
Missailidis, S. (2004) · Humana Press eBooks · doi:10.1385/1-59259-666-5:547 · Cited by 9 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Aptamer-Based Detection of Circulating Targets for Precision Medicine
Wu, L., Wang, Y., Xu, X., Liu, Y., Lin, B., Zhang, M., Zhang, J., Wan, S., Yang, C. J., & Tan, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01140 · Cited by 704 · see citing works
Nimjee, S. M., White, R. R., Becker, R. C., & Sullenger, B. A. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104558 · Cited by 616 · see citing works
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Sun, H., Zhu, X., Lu, P. Y., Rosato, R. R., Tan, W., & Zu, Y. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.32 · Cited by 541 · see citing works
Recent Advances in Subcellular Targeted Cancer Therapy Based on Functional Materials
Chen, W., Luo, G., & Zhang, X. (2018) · Advanced Materials · doi:10.1002/adma.201802725 · Cited by 378 · see citing works
The biological applications of DNA nanomaterials: current challenges and future directions
Ma, W., Zhan, Y., Zhang, Y., Mao, C., Xie, X., & Lin, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00727-9 · Cited by 336 · see citing works
Signaling pathways and therapeutic interventions in gastric cancer
Lei, Z., Teng, Q., Qin, T. L., Chen, W., Xie, Y., Wu, K., Zeng, Q., Zeng, L., Pan, Y., Chen, Z., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01190-w · Cited by 325 · see citing works
Oncogenic protein interfaces: small molecules, big challenges
Nero, T. L., Morton, C. J., Holien, J. K., Wielens, J., & Parker, M. W. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3690 · Cited by 312 · see citing works
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
Adachi, T., & Nakamura, Y. (2019) · Molecules · doi:10.3390/molecules24234229 · Cited by 300 · see citing works
Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy
Wu, X., Chen, J., Wu, M., & Zhao, J. X. (2015) · Theranostics · doi:10.7150/thno.10257 · Cited by 260 · see citing works
Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing
Ku, T., Zhang, T., Luo, H., Yen, T., Chen, P., Han, Y., & Lo, Y. (2015) · Sensors · doi:10.3390/s150716281 · Cited by 242 · see citing works
Aptamer Therapeutics in Cancer: Current and Future
Morita, Y., Leslie, M., Kameyama, H., Volk, D. E., & Tanaka, T. (2018) · Cancers · doi:10.3390/cancers10030080 · Cited by 219 · see citing works
An Intelligent DNA Nanorobot with in Vitro Enhanced Protein Lysosomal Degradation of HER2
Ma, W., Zhan, Y., Zhang, Y., Shao, X., Xie, X., Mao, C., Cui, W., Li, Q., Shi, J., Li, J., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01320 · Cited by 207 · see citing works
Dong, Y., Li, W., Gu, Z., Xing, R., Ma, Y., Zhang, Q., & Liu, Z. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201904860 · Cited by 195 · see citing works
Aptamers used for biosensors and targeted therapy
Ning, Y., Hu, J., & Lu, F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110902 · Cited by 189 · see citing works
Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy
Esposito, C. L., Cerchia, L., Catuogno, S., Vita, G. D., Dassie, J. P., Santamaria, G., Swiderski, P. M., Condorelli, G., Giangrande, P. H., & de Franciscis, V. (2014) · Molecular Therapy · doi:10.1038/mt.2014.5 · Cited by 171 · see citing works
Current Advances in Aptamers for Cancer Diagnosis and Therapy
Hori, S.-I., Herrera, A., Rossi, J. P., & Zhou, J. (2018) · Cancers · doi:10.3390/cancers10010009 · Cited by 171 · see citing works
A Single Extracellular Vesicle (EV) Flow Cytometry Approach to Reveal EV Heterogeneity
Shen, W., Guo, K., Adkins, G. B., Jiang, Q., Liu, Y., Sedano, S., Duan, Y., Yan, W., Wang, S. E., Bergersen, K. V., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201806901 · Cited by 160 · see citing works
DNA Aptamers in the Diagnosis and Treatment of Human Diseases
Zhu, Q., Liu, G., & Kai, M. (2015) · Molecules · doi:10.3390/molecules201219739 · Cited by 151 · see citing works
Molecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology
Zhang, L., Wan, S., Jiang, Y. Y., Wang, Y., Fu, T., Liu, Q., Cao, Z., Qiu, L., & Tan, W. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b10646 · Cited by 144 · see citing works
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRβ Aptamer
Camorani, S., Esposito, C. L., Rienzo, A., Catuogno, S., Iaboni, M., Condorelli, G., de Franciscis, V., & Cerchia, L. (2014) · Molecular Therapy · doi:10.1038/mt.2013.300 · Cited by 138 · see citing works
Aptamers: A promising chemical antibody for cancer therapy
Zhou, G., Wilson, G., Hebbard, L., Duan, W., Liddle, C., George, J., & Qiao, L. (2016) · Oncotarget · doi:10.18632/oncotarget.7178 · Cited by 134 · see citing works
The isolation of an RNA aptamer targeting to p53 protein with single amino acid mutation
Chen, L., Rashid, F., Shah, A., Awan, H. M., Wu, M., Liu, A., Wang, J., Zhu, T., Luo, Z., & Shan, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502159112 · Cited by 128 · see citing works
Lee, H., Dam, D. H. M., Ha, J. W., Yue, J., & Odom, T. W. (2015) · ACS Nano · doi:10.1021/acsnano.5b05138 · Cited by 121 · see citing works
Moody, P. R., Sayers, E. J., Magnusson, J. P., Alexander, C., Borri, P., Watson, P., & Jones, A. T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.178 · Cited by 118 · see citing works
Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers
Mercier, M.-C., Dontenwill, M., & Choulier, L. (2017) · Cancers · doi:10.3390/cancers9060069 · Cited by 113 · see citing works
A comparative analysis of cell surface targeting aptamers
Kelly, L., Maier, K. E., Yan, A. C., & Levy, M. (2021) · Nature Communications · doi:10.1038/s41467-021-26463-w · Cited by 114 · see citing works
Pang, X., Cui, C., Wan, S., Jiang, Y. Y., Zhang, L., Xia, L., Li, L., Li, X., & Tan, W. (2018) · Cancers · doi:10.3390/cancers10020047 · Cited by 99 · see citing works
Velu, R., Srinivasan, S., Singh, A., & DeRosa, M. C. (2019) · Analytical Biochemistry · doi:10.1016/j.ab.2019.113471 · Cited by 98 · see citing works
Gemcitabine-Incorporated G-Quadruplex Aptamer for Targeted Drug Delivery into Pancreas Cancer
Park, J. Y., Cho, Y. L., Chae, J. R., Moon, S. H., Cho, W. G., Choi, Y. J., Lee, S., & Kang, W. J. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.06.003 · Cited by 87 · see citing works
Towards open-ended evolution in self-replicating molecular systems
Duim, H., & Otto, S. (2017) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.13.118 · Cited by 72 · see citing works
Aptamer‐based extracellular vesicle isolation, analysis and therapeutics
Zhu, L., Tian, W., Yuan, L., Chi, C., Wang, Y., Xiao, Q., Zheng, M., Yang, C. J., & Song, Y. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20220019 · Cited by 83 · see citing works
Yuan, Z., Qu, J. T., Xue, F., Zheng, Y., Yang, B., Chang, Y., Yang, H., & Zhang, J. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.02.011 · Cited by 82 · see citing works
Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy
Han, J., Gao, L., Wang, J., & Wang, J. (2020) · Journal of Cancer · doi:10.7150/jca.49532 · Cited by 82 · see citing works
Zhang, J., Zhao, T., Han, F., Hu, Y., & Li, Y. (2019) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0515-x · Cited by 80 · see citing works
Electrochemical aptasensors for cancer diagnosis in biological fluids – A review
Díaz‐Fernández, A., Lorenzo-Gómez, R., Miranda‐Castro, R., de-los-Santos-Álvarez, N., & Lobo-Castañón, M. J. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.04.022 · Cited by 81 · see citing works
Self-Assembled DNA Generated Electric Current Biosensor for HER2 Analysis
Shen, C., Zeng, K., Luo, J., Li, X., Yang, M., & Rasooly, A. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01747 · Cited by 80 · see citing works
Development of Aptamer-DNAzyme based metal-nucleic acid frameworks for gastric cancer therapy
Yan, J., Bhadane, R. N., Ran, M., Ma, X., Li, Y., Zheng, D., Salo‐Ahen, O. M. H., & Zhang, H. (2024) · Nature Communications · doi:10.1038/s41467-024-48149-9 · Cited by 80 · see citing works
Tao, Y., Li, M., Kim, B., & Auguste, D. T. (2017) · Theranostics · doi:10.7150/thno.17927 · Cited by 80 · see citing works
Combinatorial Screening of DNA Aptamers for Molecular Imaging of HER2 in Cancer
Zhu, G., Zhang, H., Jacobson, O., Wang, Z., Chen, H., Yang, X., Niu, G., & Chen, X. S. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00746 · Cited by 78 · see citing works
An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer
Liu, M., Wang, Z., Tan, T., Chen, Z., Mou, X., Yu, X., Deng, Y., Lu, G., & He, N. (2018) · Theranostics · doi:10.7150/thno.28949 · Cited by 76 · see citing works
Niazi, J. H., Verma, S. K., Niazi, S., & Qureshi, A. (2014) · The Analyst · doi:10.1039/c4an01665c · Cited by 71 · see citing works
Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer
Gijs, M., Penner, G., Blackler, G., Impens, N. R. E. N., Baatout, S., Luxen, A., & Aerts, A. (2016) · Pharmaceuticals · doi:10.3390/ph9020029 · Cited by 65 · see citing works
Bai, L., Gu, C., Liu, J., Gai, P., & Li, F. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114850 · Cited by 63 · see citing works
Drug-free macromolecular therapeutics – a new paradigm in polymeric nanomedicines
Chu, T.-W., & Kopec̆ek, J. (2015) · Biomaterials Science · doi:10.1039/c4bm00442f · Cited by 61 · see citing works
Aptamers as smart ligands for nano-carriers targeting
Mokhtarzadeh, A., Tabarzad, M., Ranjbari, J., de la Guárdia, M., Hejazi, M., & Ramezani, M. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2016.06.018 · Cited by 60 · see citing works
DNA aptamer technology for personalized medicine
Xing, H., Hwang, K., Li, J., Torabi, S., & Lu, Y. (2014) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2014.01.007 · Cited by 56 · see citing works
PET imaging of HER2 expression with an 18F-fluoride labeled aptamer
Kim, H. J., Park, J. Y., Lee, T. S., Song, I. H., Cho, Y. L., Chae, J. R., Kang, H., Lim, J. H., Lee, J. H., & Kang, W. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211047 · Cited by 55 · see citing works
Expanding the chemical functionality of DNA nanomaterials generated by rolling circle amplification
Baker, Y. R., Yuan, L., Chen, J., Belle, R., Carlisle, R. C., El-Sagheer, A. H., & Brown, T. P. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab720 · Cited by 54 · see citing works
Recent advances in HER2-targeted delivery for cancer therapy
Dhritlahre, R. K., & Saneja, A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.014 · Cited by 53 · see citing works
Leveraging aptamers for targeted protein degradation
Yang, Z., Pang, Q., Zhou, J., Xuan, C., & Xie, S. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.05.008 · Cited by 50 · see citing works
Therapeutic aptamers in discovery, preclinical and clinical stages
Ismail, S. I., & Alshaer, W. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.006 · Cited by 50 · see citing works
Differentiating breast cancer molecular subtypes using a DNA aptamer selected against MCF-7 cells
Liu, M., Yang, T., Chen, Z., Wang, Z., & He, N. (2018) · Biomaterials Science · doi:10.1039/c8bm00787j · Cited by 50 · see citing works
Smith, J. D., Cardwell, L. N., Porciani, D., Nguyen, J. A., Zhang, R., Gallazzi, F., Tata, R. R., Burke, D. H., Daniëls, M. A., & Ulery, B. D. (2018) · Physical Biology · doi:10.1088/1478-3975/aadb68 · Cited by 49 · see citing works
DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors
Shishparenok, A. N., Furman, V. V., & Zhdanov, D. D. (2023) · Cancers · doi:10.3390/cancers15072151 · Cited by 50 · see citing works
Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications
Camorani, S., Crescenzi, E., Fedele, M., & Cerchia, L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.03.003 · Cited by 48 · see citing works
Aptamers: Promising Tools for the Detection of Circulating Tumor Cells
Hassan, E. M., Willmore, W. G., & DeRosa, M. C. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2016.0632 · Cited by 47 · see citing works
Malecka, K., Pankratov, D., & Ferapontova, E. E. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.05.052 · Cited by 46 · see citing works
Aptamer-Braked Multi-hairpin Cascade Circuits for Logic-Controlled Label-Free In Situ Bioimaging
Tian, Z., Peng, P., Wang, H., Zheng, J., Shi, L., & Li, T. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00583 · Cited by 46 · see citing works
Salimian, R., Kékedy‐Nagy, L., & Ferapontova, E. E. (2017) · ChemElectroChem · doi:10.1002/celc.201700025 · Cited by 45 · see citing works
Shen, Y., Zhang, J., Hao, W., Wang, T., Liu, J., Xie, Y., Xu, S., & Liu, H. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s149942 · Cited by 45 · see citing works
Chen, J., Baker, Y. R., Brown, A., El-Sagheer, A. H., & Brown, T. P. (2018) · Chemical Science · doi:10.1039/c8sc02952k · Cited by 45 · see citing works
Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies
Yang, S., Li, H., Xu, L., Deng, Z., Han, W., Liu, Y., Jiang, W., & Zu, Y. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.08.023 · Cited by 44 · see citing works
Jeevanandam, J., Tan, K. X., Danquah, M. K., Guo, H., & Turgeson, A. (2019) · Biotechnology Journal · doi:10.1002/biot.201900368 · Cited by 45 · see citing works
Gan, Z., Roslan, M. A. M., Shukor, M. Y., Halim, M., Yasid, N. A., Abdullah, J., Yasin, I. S. M., & Wasoh, H. (2022) · Biosensors · doi:10.3390/bios12110922 · Cited by 43 · see citing works
A Cancer Cell-Activatable Aptamer-Reporter System for One-Step Assay of Circulating Tumor Cells
Zeng, Z., Tung, C., & Zu, Y. (2014) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2014.36 · Cited by 43 · see citing works
Chen, K., Cai, J., Wang, S., Li, Y., Yang, C., Fu, T., Zhao, Z., Zhang, X., & Tan, W. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202208451 · Cited by 42 · see citing works
Boulbés, D. R., Arold, S. T., Chauhan, G. B., Blachno, K. V., Deng, N., Chang, W., Jin, Q., Huang, T.-H., Hsu, J.-M., Brady, S. W., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.10.011 · Cited by 41 · see citing works
Potential Diagnostic and Therapeutic Applications of Oligonucleotide Aptamers in Breast Cancer
Wu, X., Shaikh, A. B., Yu, Y., Li, Y., Ni, S., Lü, A., & Zhang, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091851 · Cited by 41 · see citing works
Pure DNA scaffolded drug delivery systems for cancer therapy
Aliouat, H., Peng, Y., Waseem, Z., Wang, S., & Zhou, W. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121532 · Cited by 37 · see citing works
Aptamers and antibodies: rivals or allies in cancer targeted therapy?
Agnello, L., Camorani, S., Fedele, M., & Cerchia, L. (2021) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2021.00035 · Cited by 37 · see citing works
Aptamers: Promising Reagents in Biomedicine Application
Zhou, H., Li, Y., & Wu, W. (2024) · Advanced Biology · doi:10.1002/adbi.202300584 · Cited by 35 · see citing works
Wen, Y., Liu, R., Xie, Y., & Li, M. (2024) · Advanced Materials · doi:10.1002/adma.202405253 · Cited by 35 · see citing works
Kissmann, A., Andersson, J., Bozdogan, A., Amann, V., Krämer, M., Hu, X., Raber, H. F., Kubiczek, D. H., Aspermair, P., Knoll, W., et al. (2022) · Nanoscale Horizons · doi:10.1039/d1nh00605c · Cited by 34 · see citing works
Targeted chimera delivery to ovarian cancer cells by heterogeneous gold magnetic nanoparticle
Chen, Y., Xu, M., Guo, Y. C., Tu, K., Wu, W., Wang, J., Tong, X., Wu, W., Qi, L., & Shi, D. (2016) · Nanotechnology · doi:10.1088/0957-4484/28/2/025101 · Cited by 34 · see citing works
Qiu, F., Xie, D., Chen, H., Wang, Z., Huang, J., Cao, C., Liang, Y., Xu, Y., He, D., Fu, X., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2024-225565 · Cited by 32 · see citing works
Xie, Y., Wen, Y., Su, X., Zheng, C., & Li, M. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02419 · Cited by 32 · see citing works
Bailey, T. A., Luan, H., Tom, E. C., Bielecki, T. A., Mohapatra, B. C., Ahmad, G., George, M., Kelly, D. L., Natarajan, A., Raja, S. M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.608992 · Cited by 32 · see citing works
Ultrasensitive Quantitation of Plasma Membrane Proteins via isRTA
Gao, T., Wang, B., Liu, S., Zhu, X., Xiang, Y., Anzai, J., & Li, G. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b02025 · Cited by 31 · see citing works
Shi, L., Peng, P., Zheng, J., Wang, Q., Tian, Z., Wang, H., & Li, T. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa020 · Cited by 31 · see citing works
Aptamers Targeting Membrane Proteins for Sensor and Diagnostic Applications
Kara, N., Ayoub, N., İlgü, H., Fotiadis, D., & İlgü, M. (2023) · Molecules · doi:10.3390/molecules28093728 · Cited by 31 · see citing works
Liang, Q., Zhou, Q., Shi, H., Wu, S., Yang, J., Zeng, T., Zhao, J. T., Yin, Y., & Li, G. (2024) · Nano Today · doi:10.1016/j.nantod.2023.102143 · Cited by 30 · see citing works
Advances in Screening and Development of Therapeutic Aptamers Against Cancer Cells
Li, Z., Fu, X., Huang, J., Zeng, P., Huang, Y., Chen, X., & Liang, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.662791 · Cited by 32 · see citing works
Dam, D. H. M., Lee, H., Lee, R. C., Kim, K. H., Kelleher, N. L., & Odom, T. W. (2015) · Bioconjugate Chemistry · doi:10.1021/bc500562s · Cited by 30 · see citing works
Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy
Lee, M., Lee, M.-J., Song, Y., Kim, S., & Park, N. (2024) · Molecules · doi:10.3390/molecules29194737 · Cited by 29 · see citing works
Dong, Y., Li, W., Gu, Z., Xing, R., Ma, Y., Zhang, Q., & Liu, Z. (2019) · Angewandte Chemie · doi:10.1002/ange.201904860 · Cited by 29 · see citing works
Wymant, J. M., Sayers, E. J., Muir, D., & Jones, A. T. (2020) · Journal of Cancer · doi:10.7150/jca.32470 · Cited by 28 · see citing works
Aptamers in immunological research
Nezlin, R. S. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.10.001 · Cited by 28 · see citing works
Organ-on-a-Chip: The Future of Therapeutic Aptamer Research?
Tran, T. T. T., Delgado‐Huertas, A., & Jeong, S. (2021) · BioChip Journal · doi:10.1007/s13206-021-00016-1 · Cited by 26 · see citing works
Photoelectrochemical detection of breast cancer biomarker based on hexagonal carbon nitride tubes
Luo, J., Liang, D., Qiu, X., & Yang, M. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02060-1 · Cited by 26 · see citing works
Bhowmik, D., Culver, K. S. B., Liu, T., & Odom, T. W. (2019) · ACS Nano · doi:10.1021/acsnano.9b03144 · Cited by 25 · see citing works
Improving Breast Cancer Treatment Specificity Using Aptamers Obtained by 3D Cell-SELEX
Nelissen, F. H. T., Peeters, W. J. M., Roelofs, T. P., Nagelkerke, A., Span, P. N., & Heus, H. A. (2021) · Pharmaceuticals · doi:10.3390/ph14040349 · Cited by 25 · see citing works
Liu, W., Wang, Y., Jiang, P., Huang, K., Zhang, H., Chen, J., & Chen, P. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116493 · Cited by 22 · see citing works
Aptamer-guided gene targeting in yeast and human cells
Ruff, P., Koh, K. D., Keskin, H., Pai, R. B., & Storici, F. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku101 · Cited by 21 · see citing works
Zhou, W., Wu, J., Zhu, Y., Meng, Z., Liu, X., Liu, S., Ni, M., Jia, S., Zhang, J., & Guo, S. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-019-2787-y · Cited by 21 · see citing works
Design and application of DNA nanostructures for organelle-targeted delivery of anticancer drugs
Sun, S., Yang, Y., Niu, H., Luo, M., & Wu, Z. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2083603 · Cited by 19 · see citing works
Classification of breast cancer by a gold nanoparticle based multicolor fluorescent aptasensor
Wu, Y., Feng, Y., & Li, X. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.12.039 · Cited by 19 · see citing works
Studies on the Affinity‐based Biosensors for Electrochemical Detection of HER2 Cancer Biomarker
Jarczewska, M., Trojan, A., Gągała, M., & Malinowska, E. (2019) · Electroanalysis · doi:10.1002/elan.201900041 · Cited by 18 · see citing works
Aptamer: A theranostic approach towards breast cancer
Rana, S., Kaushik, D., Singh, A., Gautam, D., Rai, J., & Rathore, J. S. (2023) · Clinical Immunology Communications · doi:10.1016/j.clicom.2023.06.002 · Cited by 17 · see citing works
Development of RNA aptamers as molecular probes for HER2(+) breast cancer study using cell-SELEX.
Moosavian, S. A., Jaafari, M. R., Taghdisi, S. M., Mosaffa, F., Badiee, A., & Abnous, K. (2015) · Europe PMC (PubMed Central) · Cited by 16 · see citing works
Electrochemical Cellulase-Linked ELASA for Rapid Liquid Biopsy Testing of Serum HER-2/neu
Díaz‐Fernández, A., Ferapontov, A., Vendelbo, M. H., & Ferapontova, E. E. (2023) · ACS Measurement Science Au · doi:10.1021/acsmeasuresciau.2c00067 · Cited by 15 · see citing works
- Authors
- Mahlknecht, G., Maron, R., Mancini, M., Schechter, B., Sela, M., & Yarden, Y.
- Affiliations
- Weizmann Institute of Science (IL)
- Departments of aImmunology and
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-04-29
- Volume
- 110
- Issue
- 20
- Pages
- 8170-8175
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3657787
- OpenAlex
- W2062141406
- Cited by
- 169
- References
- 26
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 14 · 2023: 10 · 2022: 16 · 2021: 13 · 2020: 15 · 2019: 14 · 2018: 16 · 2017: 10 · 2016: 8 · 2015: 12 · 2014: 13 · 2013: 1
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA072981, R01CA072981, R37CA072981)
- Topics
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Keywords
- DNA aptamers, gastric cancer, lysosomal degradation, receptor tyrosine kinase, endocytosis, tumor growth inhibition, cell surface translocation, aptamer therapeutics
- MeSH terms
- Animals, Antineoplastic Agents, Cross-Linking Reagents, Cytoplasm, DNA, Female, Humans, Lysosomes, Mice, Nude, Neoplasm Transplantation, Nucleotides, Protein Binding, Stomach Neoplasms, Receptor, ErbB-2, Erb-b2 Receptor Tyrosine Kinases, Cell Line, Tumor, Cell Proliferation, Mice, Aptamers, Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
